Evidence map›Paper›PMID 31739642›Full record

ArticleCells2019

Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo.

Renn-Chia Lin, Shun-Fa Yang, Hui-Ling Chiou, Shu-Ching Hsieh, Shiua-Hua Wen, Ko-Hsiu Lu, Yi-Hsien Hsieh

Abstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in bioengineering and biotechnology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Licochalcone A induces cell cycle arrest in human lung squamous carcinoma cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  15. Article
  16. Article
  17. Licorice (OncoTargets and therapy · 2022
    Review
  18. Review
  19. Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Renn-Chia LinInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Shun-Fa YangInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Hui-Ling ChiouSchool of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Shu-Ching HsiehInstitute of Biochemistry, Microbiology, and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan.
Shiua-Hua WenInstitute of Biochemistry, Microbiology, and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan.
Ko-Hsiu LuDepartment of Orthopedics, Chung Shan Medical University Hospital, Chung Shan Medical University, Taichung 40201, Taiwan.
Yi-Hsien HsiehInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLicochalcone A (LicA) is isolated from the roots of

methodsCell viability was measured by MTT assay. Apoptosis and mitochondrial dysfunction were detected with Annexin V/PI staining and JC-1 staining by flow cytometry. The expressions of caspase- or mitochondrial-related proteins were demonstrated by western blotting. Antitumor effect of LicA on 143B xenograft mice in vivo.

results

conclusionsThese findings demonstrate that LicA has antitumor activities against human osteosarcoma cells through p38MAPK regulation of mitochondria-mediated intrinsic apoptotic pathways in vitro and in vivo.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicBone NeoplasmsCell Line, TumorCell ProliferationCell SurvivalChalconesGene Expression Regulation, NeoplasticHumansMAP Kinase Signaling SystemMembrane Potential, MitochondrialMiceMitochondriaOsteosarcomap38 Mitogen-Activated Protein KinasesPhosphorylationAntineoplastic Agents, PhytogenicChalconeslicochalcone Ap38 Mitogen-Activated Protein KinasesapoptosisLicAMMPsosteosarcoma cellsp38MAPK

Identifiers

PMID31739642
PMCPMC6912226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.